JAMJOOM PHARMACEUTICALS FACTORY TADAWUL:4015:
H2 DIVIDEND PER SHARE SAR 2.00
Jamjoom Pharma H2 Dividend SAR 2 /Share
Jamjoom Pharmaceuticals Factory Co. on 6ix
In the deck
Story so far
Earlier from Jamjoom Pharmaceuticals Factory
- ZAWYA-PRESSR: Jamjoom Pharma Egypt signs cooperation protocol with Research Institute of Ophthalmology
- SNG: Jamjoom Pharma, PIF-backed Lifera launch JV to strengthen Saudi biopharma manufacturing ecosystem
- PRESSR: Lifera and Jamjoom Pharma launch strategic joint venture to power Saudi Arabia’s biopharma future
- SNG: Saudi: Jamjoom Pharma’s net profits near $105.6mln in 9M-25
- Jamjoom Pharma Q3 Profit SAR 106.67 Million
Later from Jamjoom Pharmaceuticals Factory
- ZAWYA: Jamjoom Pharma and Magrabi Health Group sign an MoU to enhance Ophthalmology services in Saudi Arabia
- ZAWYA: Jamjoom Pharma and Caritas Egypt launch a strategic partnership to enhance eye health
- ZAWYA: PharmaZ Career Summit concludes
- ZAWYA: Jamjoom Pharma signs agreement to acquire pharmaceutical manufacturing facility in Saudi Arabia from Pfizer
- Jamjoom Pharma Signs Letter Of Credit And Short Term Loan Facilities By Its Joint Venture In Algeria
Follow Jamjoom Pharmaceuticals Factory into a list and get an email when it puts out news.
Follow Jamjoom Pharmaceuticals Factory